维普中文期刊产品整合服务
221篇 您的检索式:期刊名="Crit Rev Oncog"
    题名 作者 年代 出处 被引量
1Methyl-group metabolism and the response of colorectal cancer to 5-fluorouracil显示文摘Iacopetta B 2006Crit Rev Oncog2006,12,12:1
2Vascular endo thelial growth factor and osteopontin in lumor biology显示文摘Shijubo N Uede T Kon S Nagata M Abe S 2000Crit Rev Oncog2000,11,:1
3Target molecules for anti-angiogenic therapy:from basic research to clinical trials显示文摘Hagedorn M Bikfalvi A 2000Crit Rev Oncog2000,34,:1
4Therapeutic targeting of the epidermal growth factor receptor in human cancer 显示文摘Dhomen NS Mariadason J Tebbutt N 2012Crit Rev Oncog2012,17,1:1
5Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics显示文摘Engelberth SA Hempel N Bergkvist M 2014Crit Rev Oncog2014,19,34:1
6EGR-1, the reluctant suppression factor:EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-betal is postulated to account for this suppressor activity 显示文摘Liu C Calogero A Ragona G 1996Crit Rev Oncog1996,7,:1
7Targeting PI3 ki- nase/AKT/mTOR signaling in cancer 显示文摘Sheppard K Kinross KM Solomon B 2012Crit Rev Oncog2012,17,1:1
8The role for transforming growth factor-beta (TGF-beta) in human cancer显示文摘Gold LI 1999Crit Rev Oncog1999,10,4:1
9The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-KB/Snail/YY1/RKIP/PTEN circuitry 显示文摘Bonavida B Baritaki S 2011Crit Rev Oncog2011,16,34:1
10The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia显示文摘Cotton S Sharp L Little J 1996Crit Rev Oncog1996,7,56:1
11Neurotrophin-Trk receptor interactions in neoplasia:a possible role in interstitial and perineural invasion in ductal pancreatic cancer显示文摘Miknyoczki SJ Klein-Szanto AJ Ruggeri BA 1996Crit Rev Oncog1996,7,12:1
12Structure and function of eukayotic proprotein processing enzymes of the subtilisin family of serine protease显示文摘Van de Ven WJ Roebroek AJ Van Duijnhoen HL 1993Crit Rev Oncog1993,4,:1
13Antiangiogenic therapies targeting the vascular endo-thelia growth factor signaling system 显示文摘Tie J Desai J 2012Crit Rev Oncog2012,17,1:1
14Critical concepts in the oncogenesis of adenocarcionoma of the rectum显示文摘Huerta S 2012Crit Rev Oncog2012,17,4:1
15Survey of Raf kinase inhibitor protein (RKIP) in multiple cancer types显示文摘Lamiman K Keller JM Mizokami A 2014Crit Rev Oncog2014,19,6:1
16Nucle- ar factor-kappa B signaling:a contributor in leukemogenesis and a target for pharmacological intervention in human acute my- elogenous leukemia 显示文摘REIKVAM H OLSNES A M GJERTSEN B T 2009Crit Rev Oncog2009,15,12:1
17Biochemical, immunological, and functional aspects of the growth-suppressor/oncoprotein p53 显示文摘Montenarh M 1992Crit Rev Oncog1992,3,3:1
18Cardiac tumors: A current clinical and pathological perspective 显示文摘Majano-Lainez RA 1997Crit Rev Oncog1997,8,:1
19p53 from basic researth to clinical applications显示文摘Tominaga O Hamelin R Remvikos Y 1992Crit Rev Oncog1992,3,3:1
20Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?显示文摘Restrepo A Raez L E Byrne G E Jr 1998Crit Rev Oncog1998,9,34:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费